Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Polarization-independent atomic prism filter for removing amplified spontaneous emission.

Cohen RD, Mullarkey CA, Howell JC, Katz N.

Appl Opt. 2018 Jun 1;57(16):4472-4476. doi: 10.1364/AO.57.004472.

PMID:
29877395
2.

The use of whole-genome sequencing in cluster investigation of a multidrug-resistant tuberculosis outbreak.

Lalor MK, Casali N, Walker TM, Anderson LF, Davidson JA, Ratna N, Mullarkey C, Gent M, Foster K, Brown T, Magee J, Barrett A, Crook DW, Drobniewski F, Thomas HL, Abubakar I.

Eur Respir J. 2018 Jun 21;51(6). pii: 1702313. doi: 10.1183/13993003.02313-2017. Print 2018 Jun.

PMID:
29748309
3.

The generation of a simian adenoviral vectored HCV vaccine encoding genetically conserved gene segments to target multiple HCV genotypes.

von Delft A, Donnison TA, Lourenço J, Hutchings C, Mullarkey CE, Brown A, Pybus OG, Klenerman P, Chinnakannan S, Barnes E.

Vaccine. 2018 Jan 4;36(2):313-321. doi: 10.1016/j.vaccine.2017.10.079. Epub 2017 Dec 2.

4.

Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in mice.

He W, Chen CJ, Mullarkey CE, Hamilton JR, Wong CK, Leon PE, Uccellini MB, Chromikova V, Henry C, Hoffman KW, Lim JK, Wilson PC, Miller MS, Krammer F, Palese P, Tan GS.

Nat Commun. 2017 Oct 10;8(1):846. doi: 10.1038/s41467-017-00928-3.

5.

Ultrasensitive inverse weak-value tilt meter.

Martínez-Rincón J, Mullarkey CA, Viza GI, Liu WT, Howell JC.

Opt Lett. 2017 Jul 1;42(13):2479-2482. doi: 10.1364/OL.42.002479.

PMID:
28957263
6.

Novel Bivalent Viral-Vectored Vaccines Induce Potent Humoral and Cellular Immune Responses Conferring Protection against Stringent Influenza A Virus Challenge.

Tully CM, Chinnakannan S, Mullarkey CE, Ulaszewska M, Ferrara F, Temperton N, Gilbert SC, Lambe T.

J Immunol. 2017 Jul 19. pii: ji1600939. doi: 10.4049/jimmunol.1600939. [Epub ahead of print]

PMID:
28724579
7.

Notes from the Field: Mortality Associated with Hurricane Matthew - United States, October 2016.

Wang A, Issa A, Bayleyegn T, Noe RS, Mullarkey C, Casani J, Nelson CL, Fleischauer A, Clement KD, Hamilton JJ, Harrison C, Edison L, Hobron K, Kurkjian KM, Choudhary E, Wolkin A; Hurricane Matthew Incident Management System Team, CDC Emergency Operations Center.

MMWR Morb Mortal Wkly Rep. 2017 Feb 10;66(5):145-146. doi: 10.15585/mmwr.mm6605a3. No abstract available.

8.

Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus.

He W, Tan GS, Mullarkey CE, Lee AJ, Lam MM, Krammer F, Henry C, Wilson PC, Ashkar AA, Palese P, Miller MS.

Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):11931-11936. Epub 2016 Oct 3.

9.

Broadly Neutralizing Hemagglutinin Stalk-Specific Antibodies Induce Potent Phagocytosis of Immune Complexes by Neutrophils in an Fc-Dependent Manner.

Mullarkey CE, Bailey MJ, Golubeva DA, Tan GS, Nachbagauer R, He W, Novakowski KE, Bowdish DM, Miller MS, Palese P.

MBio. 2016 Oct 4;7(5). pii: e01624-16. doi: 10.1128/mBio.01624-16.

10.

Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact.

Leon PE, He W, Mullarkey CE, Bailey MJ, Miller MS, Krammer F, Palese P, Tan GS.

Proc Natl Acad Sci U S A. 2016 Oct 4;113(40):E5944-E5951. Epub 2016 Sep 19.

11.

Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection.

Henry Dunand CJ, Leon PE, Huang M, Choi A, Chromikova V, Ho IY, Tan GS, Cruz J, Hirsh A, Zheng NY, Mullarkey CE, Ennis FA, Terajima M, Treanor JJ, Topham DJ, Subbarao K, Palese P, Krammer F, Wilson PC.

Cell Host Microbe. 2016 Jun 8;19(6):800-13. doi: 10.1016/j.chom.2016.05.014.

12.

Measuring the neutralization potency of influenza A virus hemagglutinin stalk/stem-binding antibodies in polyclonal preparations by microneutralization assay.

He W, Mullarkey CE, Miller MS.

Methods. 2015 Nov 15;90:95-100. doi: 10.1016/j.ymeth.2015.04.037. Epub 2015 May 6.

PMID:
25957674
13.

Mental health and quality-of-life concerns related to the burden of food allergy.

Ravid NL, Annunziato RA, Ambrose MA, Chuang K, Mullarkey C, Sicherer SH, Shemesh E, Cox AL.

Psychiatr Clin North Am. 2015 Mar;38(1):77-89. doi: 10.1016/j.psc.2014.11.004. Epub 2014 Dec 20. Review.

PMID:
25725570
14.

Broadly neutralizing anti-influenza virus antibodies: enhancement of neutralizing potency in polyclonal mixtures and IgA backbones.

He W, Mullarkey CE, Duty JA, Moran TM, Palese P, Miller MS.

J Virol. 2015 Apr;89(7):3610-8. doi: 10.1128/JVI.03099-14. Epub 2015 Jan 14.

15.

A prospective observational study of techniques to remove CFB in the ED; authors' reply.

Quirke M, Mullarkey C, Binchy J.

Emerg Med J. 2015 May;32(5):417. doi: 10.1136/emermed-2014-204487. Epub 2015 Jan 8. No abstract available.

PMID:
25573066
16.

Adenoviral vectors as novel vaccines for influenza.

Coughlan L, Mullarkey C, Gilbert S.

J Pharm Pharmacol. 2015 Mar;67(3):382-99. doi: 10.1111/jphp.12350. Epub 2015 Jan 5. Review.

PMID:
25560474
17.

Longitudinal evaluation of food allergy-related bullying.

Annunziato RA, Rubes M, Ambrose MA, Mullarkey C, Shemesh E, Sicherer SH.

J Allergy Clin Immunol Pract. 2014 Sep-Oct;2(5):639-41. doi: 10.1016/j.jaip.2014.05.001. Epub 2014 Jun 11. No abstract available.

PMID:
25213068
18.

Transmission of multidrug-resistant tuberculosis in the UK: a cross-sectional molecular and epidemiological study of clustering and contact tracing.

Anderson LF, Tamne S, Brown T, Watson JP, Mullarkey C, Zenner D, Abubakar I.

Lancet Infect Dis. 2014 May;14(5):406-15. doi: 10.1016/S1473-3099(14)70022-2. Epub 2014 Mar 4.

19.

The addition of ondansetron to a oral rehydration protocol for children with acute gastroenteritis.

Mullarkey C, Crowley E, Martin C.

Ir Med J. 2013 Oct;106(9):266-8.

PMID:
24416847
20.

Coadministration of seasonal influenza vaccine and MVA-NP+M1 simultaneously achieves potent humoral and cell-mediated responses.

Antrobus RD, Berthoud TK, Mullarkey CE, Hoschler K, Coughlan L, Zambon M, Hill AV, Gilbert SC.

Mol Ther. 2014 Jan;22(1):233-8. doi: 10.1038/mt.2013.162. Epub 2013 Jul 8.

21.

Improved adjuvanting of seasonal influenza vaccines: preclinical studies of MVA-NP+M1 coadministration with inactivated influenza vaccine.

Mullarkey CE, Boyd A, van Laarhoven A, Lefevre EA, Veronica Carr B, Baratelli M, Molesti E, Temperton NJ, Butter C, Charleston B, Lambe T, Gilbert SC.

Eur J Immunol. 2013 Jul;43(7):1940-52. doi: 10.1002/eji.201242922. Epub 2013 Jun 10.

22.

A prospective observational study of techniques to remove corneal foreign body in the emergency department.

Quirke M, Mullarkey C, Askoorum S, Coffey N, Binchy J.

Emerg Med J. 2014 Jun;31(6):463-6. doi: 10.1136/emermed-2012-201447. Epub 2013 Mar 29.

PMID:
23543227
23.

A pain in the neck--a review of deep space neck infections in the emergency department.

Harney T, Mullarkey C, O'Donnell J.

Ir Med J. 2012 Nov-Dec;105(10):345-6.

PMID:
23495549
24.

Immunity against heterosubtypic influenza virus induced by adenovirus and MVA expressing nucleoprotein and matrix protein-1.

Lambe T, Carey JB, Li Y, Spencer AJ, van Laarhoven A, Mullarkey CE, Vrdoljak A, Moore AC, Gilbert SC.

Sci Rep. 2013;3:1443. doi: 10.1038/srep01443.

25.

Child and parental reports of bullying in a consecutive sample of children with food allergy.

Shemesh E, Annunziato RA, Ambrose MA, Ravid NL, Mullarkey C, Rubes M, Chuang K, Sicherer M, Sicherer SH.

Pediatrics. 2013 Jan;131(1):e10-7. doi: 10.1542/peds.2012-1180. Epub 2012 Dec 24.

26.

T-cell responses in children to internal influenza antigens, 1 year after immunization with pandemic H1N1 influenza vaccine, and response to revaccination with seasonal trivalent-inactivated influenza vaccine.

Lambe T, Spencer AJ, Mullarkey CE, Antrobus RD, Yu LM, de Whalley P, Thompson BA, Jones C, Chalk J, Kerridge S, Hill AV, Snape MD, Pollard AJ, Gilbert SC.

Pediatr Infect Dis J. 2012 Jun;31(6):e86-91. doi: 10.1097/INF.0b013e318255e443.

PMID:
22466328
27.

Preliminary assessment of the efficacy of a T-cell-based influenza vaccine, MVA-NP+M1, in humans.

Lillie PJ, Berthoud TK, Powell TJ, Lambe T, Mullarkey C, Spencer AJ, Hamill M, Peng Y, Blais ME, Duncan CJ, Sheehy SH, Havelock T, Faust SN, Williams RL, Gilbert A, Oxford J, Dong T, Hill AV, Gilbert SC.

Clin Infect Dis. 2012 Jul;55(1):19-25. doi: 10.1093/cid/cis327. Epub 2012 Mar 22.

28.

Mental health and quality-of-life concerns related to the burden of food allergy.

Ravid NL, Annunziato RA, Ambrose MA, Chuang K, Mullarkey C, Sicherer SH, Shemesh E, Cox AL.

Immunol Allergy Clin North Am. 2012 Feb;32(1):83-95. doi: 10.1016/j.iac.2011.11.005. Epub 2011 Dec 12.

PMID:
22244234
29.

An investigation of the reliability of Rapid Upper Limb Assessment (RULA) as a method of assessment of children's computing posture.

Dockrell S, O'Grady E, Bennett K, Mullarkey C, Mc Connell R, Ruddy R, Twomey S, Flannery C.

Appl Ergon. 2012 May;43(3):632-6. doi: 10.1016/j.apergo.2011.09.009. Epub 2011 Oct 20.

PMID:
22018838
30.

Soothing a sore throat: the efficacy and safety of steroids in acute pharyngitis.

Mullarkey C.

Ir J Med Sci. 2011 Dec;180(4):837-40. doi: 10.1007/s11845-011-0719-z. Epub 2011 May 27. Review.

PMID:
21618052
31.

Maxillofacial and dental injuries sustained in hurling.

Murphy C, Ahmed I, Mullarkey C, Kearns G.

Ir Med J. 2010 Jun;103(6):174-6.

PMID:
20669600
32.

Cost-effectiveness of the NICE guidelines for screening for latent tuberculosis infection: the QuantiFERON-TB Gold IGRA alone is more cost-effective for immigrants from high burden countries.

Hardy AB, Varma R, Collyns T, Moffitt SJ, Mullarkey C, Watson JP.

Thorax. 2010 Feb;65(2):178-80. doi: 10.1136/thx.2009.119677. Epub 2009 Dec 8.

PMID:
19996345
33.

Topical anaesthesia in children: reducing the need for specialty referral.

O'Connor G, Mullarkey C.

Eur J Emerg Med. 2010 Apr;17(2):97-100. doi: 10.1097/MEJ.0b013e32832f4387.

PMID:
19593151
34.

Use of QuantiFERON-TB Gold test in the investigation of unexplained positive tuberculin skin tests.

Nsutebu E, Moffitt SJ, Mullarkey C, Schweiger MS, Collyns T, Watson JP.

Public Health. 2008 Nov;122(11):1284-7. doi: 10.1016/j.puhe.2007.12.007. Epub 2008 May 16.

PMID:
18486165
35.

Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes.

Mullarkey CJ, Edelstein D, Brownlee M.

Biochem Biophys Res Commun. 1990 Dec 31;173(3):932-9.

PMID:
2176495

Supplemental Content

Loading ...
Support Center